Thirty-one children participated in this study, ranging from 6 to 10 years of age (mean age: 7.33 ± 0.21 years old); nine children were between 6 and 7 years old, nine were between 7 and 8 years old, six were between 8 and 9 years old, and seven were between 9 and 10 years old. They were recruited through contacts with friends and families. All subjects were healthy, did not present neurologic, vestibular, or ophthalmologic symptoms that could affect their performance, and had normal or corrected-to-normal vision (the range of visual acuities was 8/10 to 12/10, and range of stereoacuities were 30 to 60 arc seconds. The dominant eye was measured with the unilateral cover test: the subject fixated on a target at 5 m, and the orthoptist covered alternately each eye, observing the viewing eye. If the viewing eye did not move, then it was considered the dominant eye. This test is one of the most commonly used techniques in clinical evaluation. The stereoacuity was measured with the TNO test (test of stereopsis). The investigation adhered to the principles of the Declaration of Helsinki and was approved by our institutional human experimentation committee, the Comité de Protection des Personnes Ile de France VI (no. 07035), Necker Hospital in Paris, France. Informed parental consent was obtained for each subject.